Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 GVR’s internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Sports Nutrition Snapshot
Chapter 3 Global Sports Nutrition Market Variables, Trends, & Scope
3.1 Penetration and Growth Prospect Mapping
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.2.3 Industry Challenges
3.3 Global Sports Nutrition Market Analysis Tools
3.3.1 Industry Analysis – Porter’s
3.3.1.1 Bargaining power of the suppliers
3.3.1.2 Bargaining power of the buyers
3.3.1.3 Threats of substitution
3.3.1.4 Threats from new entrants
3.3.1.5 Competitive rivalry
3.3.2 PESTEL Analysis
3.3.2.1 Political landscape
3.3.2.2 Economic and Social landscape
3.3.2.3 Technology landscape
3.3.2.4 Legal landscape
3.3.2.5 Technology landscape
Chapter 4 Sports Nutrition Market: Product Type Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Global Sports Nutrition Market: Product Market Share Analysis, 2019 and 2027
4.3 Sports drinks
4.3.1 Sports drinks analysis market estimates and forecasts, 2016-2027 (USD million)
4.4 Sports supplements
4.4.1 Sports supplements analysis market estimates and forecasts, 2016-2027 (USD million)
4.5 Sports food
4.5.1 Sports food analysis market estimates and forecasts, 2016-2027 (USD million)
Chapter 5 Sports Nutrition Market: Distribution Channel Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Sports Nutrition Market: Distribution Channel Market Share Analysis, 2019 and 2027
5.3 E-commerce
5.3.1 E-commerce analysis market estimates and forecasts, 2016-2027 (USD million)
5.4 Bricks and mortar
5.4.1 Bricks and mortar analysis market estimates and forecasts, 2016-2027 (USD million)
Chapter 6 Sports Nutrition Market: Regional Estimates & Trend Analysis, By Product and Distribution Channel
6.1 Global Sports Nutrition Market: Regional Movement Analysis
6.2 North America
6.2.1 North America sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.2.3 Canada
6.2.3.1 Canada sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3 Europe
6.3.1 Europe sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.3 Germany
6.3.3.1 Germany sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.4 France
6.3.4.1 France sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.5 Italy
6.3.5.1 Italy sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.6 Spain
6.3.6.1 Spain sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.2 Japan
6.4.2.1 Japan sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.3 China
6.4.3.1 China sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.4 India
6.4.4.1 India sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.5 Australia
6.4.5.1 Australia sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.6 New Zealand
6.4.6.1 New Zealand sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5 Latin America
6.5.1 Latin America sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6 MEA
6.6.1 MEA sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6.4 UAE
6.6.4.1 UAE sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
Chapter 7 Competitive Landscape
7.1 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.2 Company Profiles
7.3 Glanbia Plc
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 AirStrip Technologies
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 Hormel Foods Corporation
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 General Nutrition Centers, Inc.
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic initiatives
7.7 Abbott
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic Initiatives
7.8 Science in Sport
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 The Hut Group
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic Initiatives
7.10 Iovate Health Sciences International Inc.
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic Initiatives
7.11 Cardiff Sports Nutrition LTD.
7.11.1 Company overview
7.11.2 Financial performance
7.11.3 Product benchmarking
7.11.4 Strategic Initiatives
7.12 Clif Bar & Company
7.12.1 Company overview
7.12.2 Financial performance
7.12.3 Product benchmarking
7.12.4 Strategic Initiatives
7.13 MUSCLEPHARM
7.13.1 Company overview
7.13.2 Financial performance
7.13.3 Product benchmarking
7.13.4 Strategic Initiatives
7.14 Nature’s Bounty
7.14.1 Company overview
7.14.2 Financial performance
7.14.3 Product benchmarking
7.14.4 Strategic Initiatives
7.15 POST HOLDINGS, INC.
7.15.1 Company overview
7.15.2 Financial performance
7.15.3 Product benchmarking
7.15.4 Strategic Initiatives
TABLE 1 Ongoing projects for CAR T-cell therapies
TABLE 2 Non-viral DNA vectors (non-replicating) in gene therapy trials
TABLE 3 Some of the examples of molecules under development based on lentiviral vectors
TABLE 4 Molecules in development based on AAV vectors
TABLE 5 North America gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 6 North America gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 7 U.S. gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 8 U.S. gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 9 Canada gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 10 Canada gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 11 Europe gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 12 Europe gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 13 Asia Pacific gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 14 Asia Pacific gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 15 China gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 16 China gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 17 Japan gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 18 Japan gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 19 Russia gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 20 Russia gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 21 Australia gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 22 Australia gene therapy market, by vector type, 2016 - 2027 (USD Million)
List of Figures
FIG. 1 Market summary (USD Million)
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Global gene therapy pipeline as of 2017, by phase of trial
FIG. 12 Global cancer incidence, as of September 2018
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Gene therapy prices by eligible patients per year
FIG. 15 Annual Investment in the CAR-T Space, 2013 - 2026
FIG. 16 Global financings in cell therapy, 2016-2018
FIG. 17 Recent and ongoing manufacturing capacity expansions for viral vector and large-scale cell therapies, as of 2017
FIG. 18 SWOT Analysis, By Factor (Political & legal, economic and technological)
FIG. 19 Porter’s Five Forces Analysis
FIG. 20 Gene therapy market: Indication outlook key takeaways
FIG. 21 Gene therapy market: Indication movement analysis
FIG. 22 Global gene therapy market for Acute Lymphoblastic Leukemia (ALL), 2016 - 2027 (USD Million)
FIG. 23 Global gene therapy market for inherited retinal disease, 2016 - 2027 (USD Million)
FIG. 24 Global gene therapy market for large B-cell lymphoma, 2016 - 2027 (USD Million)
FIG. 25 Global gene therapy market for ADA-SCID, 2016 - 2027 (USD Million)
FIG. 26 Global gene therapy market for melanoma (lesions), 2016 - 2027 (USD Million)
FIG. 27 Global gene therapy market for Beta-Thalassemia Major/SCD, 2016 - 2027 (USD Million)
FIG. 28 Global gene therapy market for head & neck squamous cell carcinoma, 2016 - 2027 (USD Million)
FIG. 29 Global gene therapy market for peripheral arterial disease, 2016 - 2027 (USD Million)
FIG. 30 Global gene therapy market for Spinal Muscular Atrophy (SMA), 2016 - 2027 (USD Million)
FIG. 31 Global gene therapy market for other indications, 2016 - 2027 (USD Million)
FIG. 32 Gene therapy market vector type outlook: Key takeaways
FIG. 33 Gene therapy market: Vector type movement analysis
FIG. 34 Global lentivirus-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 35 Global AAV-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 36 Global retrovirus and gammaretrovirus vector-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 37 Global modified herpes simplex virus vectors-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 38 Global adenovirus vectors-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 39 Global non-viral plasmid vector-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 40 Regional market place: Key takeaways
FIG. 41 Stem cells & non-stem cells regional outlook, 2019 & 2027
FIG. 42 North America gene therapy market, 2016 - 2027 (USD Million)
FIG. 43 U.S. gene therapy market, 2016 - 2027 (USD Million)
FIG. 44 Canada gene therapy market, 2016 - 2027 (USD Million)
FIG. 45 Europe gene therapy market, 2016 - 2027 (USD Million)
FIG. 46 Asia Pacific gene therapy market, 2016 - 2027 (USD Million)
FIG. 47 China gene therapy market, 2016 - 2027 (USD Million)
FIG. 48 Japan gene therapy market, 2016 - 2027 (USD Million)
FIG. 49 Russia gene therapy market, 2016 - 2027 (USD Million)
FIG. 50 Australia gene therapy market, 2016 - 2027 (USD Million)
FIG. 51 Strategy framework
【免責事項】
https://www.marketreport.jp/reports-disclaimer